Global Hemophilia Treatment Market Research Report 2021

August 2016 | 103 pages | ID: G80AB85AFC4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Hemophilia Treatment

Revenue, means the sales value of Hemophilia Treatment

This report studies Hemophilia Treatment in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Novo Nordisk
• Bayer HealthCare
• Wyeth Pharmaceuticals
• Baxter AG
• HUALAN BIO
• Shanghai RAAS
• Shanghai Institute of Biological Products

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Hemophilia Treatment in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• DDAVP
• Recombinant coagulation factor
• Coagulation factor derived from donated human blood

Split by application, this report focuses on sales, market share and growth rate of Hemophilia Treatment in each application, can be divided into

• Hemophilia A
• Hemophilia B
• Hemophilia C

Contents

Global Hemophilia Treatment Market Research Report 2021

1 HEMOPHILIA TREATMENT OVERVIEW

1.1 Product Overview and Scope of Hemophilia Treatment
1.2 Hemophilia Treatment Segment by Types
  1.2.1 Global Sales Market Share of Hemophilia Treatment by Type in 2015
  1.2.2 DDAVP
  1.2.3 Recombinant coagulation factor
  1.2.4 Coagulation factor derived from donated human blood
1.3 Hemophilia Treatment Segment by Applications
  1.3.1 Hemophilia A
  1.3.2 Hemophilia B
  1.3.3 Hemophilia C
1.4 Hemophilia Treatment Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Hemophilia Treatment (2011-2021)
  1.5.1 Global Hemophilia Treatment Sales and Revenue (2011-2021)
  1.5.2 Global Hemophilia Treatment Sales and Growth Rate (2011-2021)
  1.5.3 Global Hemophilia Treatment Revenue and Growth Rate (2011-2021)

2 GLOBAL HEMOPHILIA TREATMENT MARKET COMPETITION BY MANUFACTURERS

2.1 Global Hemophilia Treatment Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Hemophilia Treatment Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Hemophilia Treatment Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL HEMOPHILIA TREATMENT ANALYSIS BY REGION

3.1 Global Hemophilia Treatment Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Hemophilia Treatment Sales Market Share by Region (2011-2021)
  3.1.2 Global Hemophilia Treatment Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Hemophilia Treatment Sales, Revenue and Price (2011-2021)
  3.2.2 North America Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Hemophilia Treatment Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Hemophilia Treatment Sales, Revenue and Price (2011-2021)
  3.4.2 China Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Hemophilia Treatment Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Hemophilia Treatment Sales, Revenue and Price (2011-2021)
  3.6.2 India Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Hemophilia Treatment Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL HEMOPHILIA TREATMENT ANALYSIS BY TYPE

4.1 Global Hemophilia Treatment Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Hemophilia Treatment Sales and Market Share by Type (2011-2021)
  4.1.2 Global Hemophilia Treatment Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 DDAVP Sales, Revenue, Price and Growth (2011-2021)
4.3 Recombinant coagulation factor Sales, Revenue, Price and Growth (2011-2021)
4.4 Coagulation factor derived from donated human blood Sales, Revenue, Price and Growth (2011-2021)

5 GLOBAL HEMOPHILIA TREATMENT MARKET ANALYSIS BY APPLICATION

5.1 Global Hemophilia Treatment Sales and Market Share by Application (2011-2021)
5.2 Major Regions Hemophilia Treatment Sales by Application in 2015 and 2016
  5.2.1 North America Hemophilia Treatment Sales by Application
  5.2.2 Europe Hemophilia Treatment Sales by Application
  5.2.3 China Hemophilia Treatment Sales by Application
  5.2.4 Japan Hemophilia Treatment Sales by Application
  5.2.5 India Hemophilia Treatment Sales by Application
  5.2.6 Southeast Asia Hemophilia Treatment Sales by Application

6 GLOBAL HEMOPHILIA TREATMENT MANUFACTURERS ANALYSIS

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hemophilia Treatment Product Overview
    6.1.2.1 DDAVP
    6.1.2.2 Recombinant coagulation factor
    6.1.2.3 Coagulation factor derived from donated human blood
  6.1.3 Hemophilia Treatment Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
6.2 Bayer HealthCare
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hemophilia Treatment Product Overview
    6.2.2.1 DDAVP
    6.2.2.2 Recombinant coagulation factor
    6.2.2.3 Coagulation factor derived from donated human blood
  6.2.3 Hemophilia Treatment Sales, Revenue, Price of Bayer HealthCare (2015 and 2016)
6.3 Wyeth Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hemophilia Treatment Product Overview
    6.3.2.1 DDAVP
    6.3.2.2 Recombinant coagulation factor
    6.3.2.3 Coagulation factor derived from donated human blood
  6.3.3 Hemophilia Treatment Sales, Revenue, Price of Wyeth Pharmaceuticals (2015 and 2016)
6.4 Baxter AG
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hemophilia Treatment Product Overview
    6.4.2.1 DDAVP
    6.4.2.2 Recombinant coagulation factor
  6.4.3 Hemophilia Treatment Sales, Revenue, Price of Baxter AG (2015 and 2016)
6.5 HUALAN BIO
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hemophilia Treatment Product Overview
    6.5.2.1 DDAVP
    6.5.2.2 Recombinant coagulation factor
  6.5.3 Hemophilia Treatment Sales, Revenue, Price of HUALAN BIO (2015 and 2016)
6.6 Shanghai RAAS
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hemophilia Treatment Product Overview
    6.6.2.1 DDAVP
    6.6.2.2 Recombinant coagulation factor
  6.6.3 Hemophilia Treatment Sales, Revenue, Price of Shanghai RAAS (2015 and 2016)
6.7 Shanghai Institute of Biological Products
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Hemophilia Treatment Product Overview
    6.7.2.1 DDAVP
    6.7.2.2 Recombinant coagulation factor
  6.7.3 Hemophilia Treatment Sales, Revenue, Price of Shanghai Institute of Biological Products (2015 and 2016)

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia Treatment
Figure Global Sales Market Share of Hemophilia Treatment by Type in 2015
Table Hemophilia Treatment Product Type of by Manufacturers
Table Hemophilia Treatment Sales Market Share by Application in 2015 and 2016
Figure North America Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Figure China Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Figure Europe Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Figure Japan Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Figure India Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Table Global Hemophilia Treatment Sales and Revenue (2011-2021)
Figure Global Hemophilia Treatment Sales and Growth Rate (2011-2021)
Figure Global Hemophilia Treatment Revenue and Growth Rate (2011-2021)
Table Global Hemophilia Treatment Sales of Key Manufacturers (2015 and 2016)
Table Global Hemophilia Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hemophilia Treatment Sales Share by Manufacturers
Figure 2016 Hemophilia Treatment Sales Share by Manufacturers
Table Global Hemophilia Treatment Revenue by Manufacturers (2015 and 2016)
Table Global Hemophilia Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Hemophilia Treatment Revenue Share by Manufacturers
Table 2016 Global Hemophilia Treatment Revenue Share by Manufacturers
Table Manufacturers Hemophilia Treatment Manufacturing Base Distribution and Product Type
Table Global Hemophilia Treatment Sales Market by Region (2011-2021)
Figure Global Hemophilia Treatment Sales Market by Region (2011-2021)
Figure Global Hemophilia Treatment Sales Market Share by Region (2011-2021)
Table Global Hemophilia Treatment Revenue Market by Region (2011-2021)
Table Global Hemophilia Treatment Revenue Market Share by Region (2011-2021)
Table North America Hemophilia Treatment Sales, Revenue and Price (2011-2021)
Figure North America Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
Table Europe Hemophilia Treatment Sales, Revenue and Price (2011-2021)
Figure Europe Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
Table China Hemophilia Treatment Sales, Revenue and Price (2011-2021)
Figure China Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
Table Japan Hemophilia Treatment Sales, Revenue and Price (2011-2021)
Figure Japan Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
Table India Hemophilia Treatment Sales, Revenue and Price (2011-2021)
Figure India Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Hemophilia Treatment Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Hemophilia Treatment Sales, Revenue and Growth Rate (2011-2021)
Table Global Hemophilia Treatment Sales by Type (2011-2021)
Table Global Hemophilia Treatment Sales Share by Type (2011-2021)
Figure Sales Market Share of Hemophilia Treatment by Type (2011-2021)
Figure Global Hemophilia Treatment Sales Growth Rate by Type (2011-2021)
Table Global Hemophilia Treatment Revenue by Type (2011-2021)
Table Global Hemophilia Treatment Revenue Share by Type (2011-2021)
Figure Global Hemophilia Treatment Revenue Growth Rate by Type (2011-2021)
Figure DDAVP Sales, Revenue and Growth (2011-2021)
Figure DDAVP Price Trend (2011-2021)
Figure Recombinant coagulation factor Sales, Revenue and Growth (2011-2021)
Figure Recombinant coagulation factor Price Trend (2011-2021)
Figure Coagulation factor derived from donated human blood Sales, Revenue and Growth (2011-2021)
Figure Coagulation factor derived from donated human blood Price Trend (2011-2021)
Table Global Hemophilia Treatment Sales by Application (2011-2021)
Table Global Hemophilia Treatment Sales Market Share by Application (2011-2021)
Figure Global Hemophilia Treatment Sales Market Share by Application in 2015
Figure Global Hemophilia Treatment Sales Market Share by Application in 2021
Table North America Hemophilia Treatment Sales by Application (2015 and 2016)
Table Europe Hemophilia Treatment Sales by Application (2015 and 2016)
Table China Hemophilia Treatment Sales by Application (2015 and 2016)
Table Japan Hemophilia Treatment Sales by Application (2015 and 2016)
Table India Hemophilia Treatment Sales by Application (2015 and 2016)
Table Southeast Asia Hemophilia Treatment Sales by Application (2015 and 2016)
Table Global Hemophilia Treatment Sales Growth Rate by Application (2011-2021)
Figure Global Hemophilia Treatment Sales Growth Rate by Application (2011-2021)
Table Novo Nordisk Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
Table Bayer HealthCare Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of Bayer HealthCare (2015 and 2016)
Table Wyeth Pharmaceuticals Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of Wyeth Pharmaceuticals (2015 and 2016)
Table Baxter AG Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of Baxter AG (2015 and 2016)
Table HUALAN BIO Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of HUALAN BIO (2015 and 2016)
Table Shanghai RAAS Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of Shanghai RAAS (2015 and 2016)
Table Shanghai Institute of Biological Products Basic Information List
Table Hemophilia Treatment Sales, Revenue, Price of Shanghai Institute of Biological Products (2015 and 2016)